HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G S Eisenbarth Selected Research

Class 8 Receptor-Like Protein Tyrosine Phosphatases

4/2001Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen.
3/2001Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs.
1/2001Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
10/2000Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in Type I diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G S Eisenbarth Research Topics

Disease

25Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2013 - 02/2000
5Autoimmune Diseases (Autoimmune Disease)
04/2007 - 01/2001
3Celiac Disease (Celiac Sprue)
10/2006 - 09/2000
3Genetic Predisposition to Disease (Genetic Predisposition)
12/2004 - 01/2001
2Insulinoma
09/2005 - 04/2001
2Addison Disease (Addison's Disease)
11/2003 - 08/2002
1Type 2 Diabetes Mellitus (MODY)
12/2011
1Insulin Resistance
06/2006
1Diabetes Mellitus
09/2005
1Virus Diseases (Viral Diseases)
06/2004
1Primary Ovarian Insufficiency
11/2003
1Tuberculosis (Tuberculoses)
11/2003
1Disease Progression
05/2001
112 Insulin-Dependent Diabetes Mellitus
01/2001
1IgA Deficiency
09/2000
1Common Variable Immunodeficiency
09/2000

Drug/Important Bio-Agent (IBA)

13Insulin (Novolin)FDA Link
11/2009 - 02/2000
9AutoantigensIBA
12/2011 - 02/2000
8AutoantibodiesIBA
12/2011 - 02/2000
4Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA
04/2001 - 10/2000
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2001 - 03/2000
3HLA-DR Antigens (HLA-DR)IBA
07/2011 - 01/2001
3Peptides (Polypeptides)IBA
09/2005 - 11/2001
3Proteins (Proteins, Gene)FDA Link
04/2001 - 10/2000
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2001 - 10/2000
2AntigensIBA
02/2009 - 09/2005
2Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
09/2005 - 03/2001
2TransglutaminasesIBA
12/2003 - 09/2000
2AntibodiesIBA
11/2003 - 09/2000
2micaIBA
08/2002 - 01/2001
2EpitopesIBA
11/2001 - 04/2001
2Tyrosine (L-Tyrosine)FDA Link
04/2001 - 03/2001
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2013
1Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
01/2013
1HLA-B Antigens (HLA-B)IBA
07/2011
1C-PeptideIBA
04/2010
1Neurofibromin 2 (Merlin)IBA
02/2009
1Glutens (Glutelin)IBA
10/2006
1GliadinIBA
10/2006
1Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
09/2005
1Chaperonin 60IBA
09/2005
1Carboxypeptidase H (Carboxypeptidase E)IBA
09/2005
1Interferon alpha-2 (Roferon-A)FDA Link
06/2004
1CytokinesIBA
06/2004
1Interferon-alpha (Interferon Alfa)IBA
06/2004
1Steroid 21-Hydroxylase (21 Hydroxylase)IBA
11/2003
1EnzymesIBA
11/2003
1Genetic Markers (Genetic Marker)IBA
08/2002
1Transcription Factors (Transcription Factor)IBA
05/2002
1ProinsulinIBA
11/2001
1Glucose (Dextrose)FDA LinkGeneric
07/2001
1InsulinsIBA
07/2001
1Messenger RNA (mRNA)IBA
04/2001
1HLA-DQB1 antigen (HLA DQB1)IBA
03/2001
1Biological ProductsIBA
10/2000
1tyrosine receptor (receptor, tyrosine)IBA
10/2000
1Glycoproteins (Glycoprotein)IBA
10/2000
1Immunoglobulins (Immunoglobulin)IBA
09/2000
1Immunoglobulin G (IgG)IBA
09/2000

Therapy/Procedure

1Therapeutics
06/2004